- Home
- LTBR vs NTRB Comparison
LTBR vs NTRB Comparison
Compare LTBR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- NTRB
- Stock Information
- Founded
- LTBR 1992
- NTRB 2016
- Country
- LTBR United States
- NTRB United States
- Employees
- LTBR N/A
- NTRB N/A
- Industry
- LTBR Professional Services
- NTRB Industrial Specialties
- Sector
- LTBR Consumer Discretionary
- NTRB Health Care
- Exchange
- LTBR Nasdaq
- NTRB Nasdaq
- Market Cap
- LTBR 45.5M
- NTRB 46.4M
- IPO Year
- LTBR N/A
- NTRB N/A
- Fundamental
- Price
- LTBR $8.03
- NTRB $8.53
- Analyst Decision
- LTBR
- NTRB Buy
- Analyst Count
- LTBR 0
- NTRB 1
- Target Price
- LTBR N/A
- NTRB $13.00
- AVG Volume (30 Days)
- LTBR 2.0M
- NTRB 428.5K
- Earning Date
- LTBR 02-26-2025
- NTRB 12-04-2024
- Dividend Yield
- LTBR N/A
- NTRB N/A
- EPS Growth
- LTBR N/A
- NTRB N/A
- EPS
- LTBR N/A
- NTRB N/A
- Revenue
- LTBR N/A
- NTRB $2,021,771.00
- Revenue This Year
- LTBR N/A
- NTRB N/A
- Revenue Next Year
- LTBR N/A
- NTRB N/A
- P/E Ratio
- LTBR N/A
- NTRB N/A
- Revenue Growth
- LTBR N/A
- NTRB N/A
- 52 Week Low
- LTBR $2.21
- NTRB $2.22
- 52 Week High
- LTBR $14.20
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- LTBR 59.94
- NTRB 70.82
- Support Level
- LTBR $5.12
- NTRB $3.96
- Resistance Level
- LTBR $10.45
- NTRB $11.78
- Average True Range (ATR)
- LTBR 1.08
- NTRB 0.85
- MACD
- LTBR 0.39
- NTRB 0.55
- Stochastic Oscillator
- LTBR 55.51
- NTRB 58.76
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through Nuclear Fuel Technology segment. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.